Found 8 matching trials
Shortening Treatment by Advancing Novel Drugs
PHASE3The purpose of this study is to assess the efficacy, safety and tolerabilit...
Location
National Center for Tuberculosis and Lung Diseases
Asymptomatic TB With Innovative Modified Short-course Regimens
PHASE4This study is a randomized controlled trial among asymptomatic tuberculosis...
Location
Beijing Chest Hospital, Capital Medical University
Rifapentine-Based Shorter Regimens for Tuberculosis and TB Infection in Kazakhstan
N/ARIFA-REAL is a prospective observational longitudinal study evaluating the ...
Location
Multiple Locations
Phase 2 Trial Assessing TBAJ876 or Bedaquiline, With Pretomanid and Linezolid in Adults With Drug-sensitive Pulmonary Tuberculosis
PHASE2The goal of this clinical trial is to evaluate 3 dose levels of TBAJ876 for...
Status
Active Not Recruiting
Location
National Center for Tuberculosis and Lung Diseases
Drug Exposure and Safety of a Shorter Tuberculosis Treatment Based on High-Dose Rifampicin and Pyrazinamide
PHASE2Tuberculosis (TB) treatment is long and complex with the risk of poor treat...
Location
Linköping University Hospital
Short Course Regimen in Low Risk Active Tuberculosis- a Multicenter, Randomized, Active-controlled, Trial
PHASE3Tuberculosis remains an important global health problem, and the world is c...
Location
Far Eastern Memorial Hospital
Trial to Evaluate the Efficacy, Safety and Tolerability of BPaMZ in Drug-Sensitive (DS-TB) Adult Patients and Drug-Resistant (DR-TB) Adult Patients
PHASE2To evaluate the efficacy, safety and tolerability at 8 weeks (2-months), 52...
Efficacy and Safety Evaluation of Two to Four Months of Treatment With the Combination Regimens of DBOS and PBOS in Adults With Pulmonary Tuberculosis
PHASE2This multicenter, two-stage, open-label, randomized trial will aim to asses...
Location
Tropical Disease Foundation
Treatments Being Tested
Delamanid, Bedaquiline, OPC-167832, and Sutezolid (DBOS)Pretomanid, Bedaquiline, OPC-167832, and Sutezolid (PBOS)Isoniazid, Rifampicin, Pyrazinamide, Ethambutol (HRZE)Pretomanid or Delamanid, Bedaquiline, OPC-167832, and Sutezolid (XBOS)Isoniazid and Rifampicin (HR)